QA: Edesa Biotech Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001540159_2024_Edesa_Biotech_Inc.pdf

Logs

Graph

Absolute values for 0001540159, Edesa Biotech Inc

  xvar xval
0 AssetsCurrent 6,436,852
1 IntangibleAssetsNetIncludingGoodwill 2,180,020
2 PropertyPlantAndEquipmentNet 8,702
3 remainder_Assets 264,863
4 LiabilitiesCurrent 1,821,864
5 LiabilitiesNoncurrent 19,773
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 800
11 remainder_Revenues 0
12 remainder_NetIncome -11,708,533
13 remainder_ComprehensiveNetIncome -1,496
  yvar yval
0 Assets 8,890,437
1 Liabilities 1,841,637
2 Expenses 800
3 Revenues 0
4 StockholdersEquity 7,048,800
5 NetIncome -11,709,333
6 ComprehensiveNetIncome -11,710,081
7 BaseVar 11,221,452
8 EconomicCapitalRatiobeforeLimitedLiability 0.681
9 EconomicCapitalRatio 2.04

Edgar->Model Mapping

Feature Distribution

Change over Time